2.1 DCP and the Commission of Pharmacy

Why the DCP–Commission split is tested

Connecticut does not run pharmacy through a standalone board sitting outside state government. CGS § 20-572 creates a Commission of Pharmacy in the Department of Consumer Protection (DCP). The CT MPJE expects you to know who writes policy and recommends discipline versus who actually inspects the pharmacy, operates the Connecticut Prescription Monitoring and Reporting System (CPMRS), and issues a deficiency letter. Mixing those roles is a classic wrong-answer pattern: candidates treat the Commission as the inspector, or treat Drug Control as the body that appoints itself.

You practice under both at once. The Commission is the professional body for pharmacy practice. DCP—through the Commissioner of Consumer Protection and the Drug Control Division—is the agency that employs inspectors and runs day-to-day enforcement. Licensure paperwork may flow through Commission staff, but a Saturday morning inspection is a Drug Control event.

Commission membership (CGS § 20-572)

The statute is specific, and the exam quotes the specifics. There shall be in the department a Commission of Pharmacy that consists of seven persons appointed by the Governor, subject to CGS § 4-9a:

• Five pharmacists, each actively engaged in the practice of pharmacy on a full-time basis in Connecticut during the term of appointment
• Two public members

Of those five pharmacist members:

• At least two shall be community retail pharmacists
• Of those two, one from an independent retail setting and one from a chain retail setting
• At least one shall be a pharmacist employed on a full-time basis as a pharmacist in a hospital in the state during the term

Members may be selected from lists nominated by the Connecticut Pharmacists Association or other professional associations of pharmacists or pharmacies. Any vacancy is filled by the Governor.

Memorize the 7 / 5 / 2 split and the independent-plus-chain-plus-hospital overlay. Distractors often claim that all five pharmacists must be community pharmacists, that hospital practice is optional, or that the Commissioner of Consumer Protection appoints the Commission. Appointment is gubernatorial. Public members are the consumer seats; they are not a second cohort of practicing pharmacists.

Current names on DCP's Commission page change and are not MPJE content. The statutory composition is.

Supervision and powers

CGS § 20-574 is one sentence with a lot of exam weight: the commissioner shall exercise supervision over the operations of the commission pursuant to CGS §§ 20-570 to 20-630. The Commission is inside DCP, not a rogue board.

CGS § 20-575 then lists what the Commission may actually do:

• Administer and enforce §§ 20-570 to 20-630 (the Pharmacy Practice Act range)
• Exercise the powers in CGS §§ 21a-7 and 21a-9, plus further powers that are reasonable and necessary to protect the public interest
• Compel attendance of witnesses and production of documents by subpoena, and administer oaths; a Superior Court judge may enforce a refusal
• Apply to the Superior Court—through the Attorney General—for a temporary or permanent injunction (and a temporary restraining order) against violations of the Act or of regulations the commissioner adopts with the commission's advice and assistance, whether or not an adequate remedy at law exists

DCP's Commission page states the practical jurisdiction: the Commission has jurisdiction over pharmacy practice and approves licensure and registration of pharmacies, pharmacists, and pharmacy interns. Enforcement actions against practitioners appear in the monthly minutes. That is policy, licensure recommendation, and discipline—not the inspection clipboard.

Who inspects: Drug Control (CGS § 20-577)

The commissioner, not the Commission as a body, employs inspectors. Under § 20-577:

• Inspectors inspect all pharmacies and other places in which drugs and devices are or may be dispensed or retailed, and report violations of §§ 20-570 to 20-630, other drug and device laws, pharmacy licenses, nonlegend drug permits, pharmacist licenses, and intern and technician supervision
• The commissioner inspects correctional and juvenile training institutions and care-giving institutions for drug handling, and may inspect dispensing outpatient facilities and institutional pharmacies
• Each retail pharmacy is inspected not less than once every four years, with a sampling methodology for dispensed prescriptions based on prescription volume

DCP's Drug Control Division is the operational home of that work. The Division regulates persons and firms involved in distributing legal drugs, medical devices, and cosmetics in Connecticut: pharmacies, pharmacists, controlled-substance providers and laboratories, pharmacy technicians, manufacturers, and wholesalers. It also runs the Prescription Monitoring Program. When an item says 'inspector,' 'audit of the CII perpetual inventory,' or 'CPMRS outage,' think Drug Control, not a Commission meeting.

Who does what

Contact and the official compilation

Use the published DCP channels; the MPJE will not grade your email hygiene, but practice items love the wrong inbox.

• Pharmacist licensing and intern registration: DCP.PharmacistLicense@ct.gov
• Commission / Board Administrator phone: 860-713-6070; fax 860-706-1242
• Mail: Department of Consumer Protection, Commission of Pharmacy, 450 Columbus Boulevard, Suite 901, Hartford, CT 06103
• Pharmacy licensing: DCP.PharmacyLicense@ct.gov
• Pharmacy/pharmacist complaints: DCP.DrugControl@ct.gov (Drug Control compliance is also published at 860-713-6065)
• Official one-stop law book: DCP Connecticut Comprehensive Drug Laws PDF, linked from the Drug Control Laws and Regulations page

DCP lists Commission meetings on selected last Wednesdays at 450 Columbus Blvd. Meeting dates are operational, not a membership rule. If a first-time pharmacist manager needs to be placed on the agenda, DCP directs that request to DCP.PharmacyCommission@ct.gov—another reminder that Commission process and Drug Control inspection are different doors in the same building.

Scenario: inspection versus discipline

A Drug Control inspector cites missing Schedule II perpetual-inventory entries and a community technician-ratio problem. The pharmacist manager tells staff, 'Only the Commission can inspect us—ignore the inspector until the next Commission meeting.' That advice is unlawful. § 20-577 inspectors work for the commissioner. The Commission may later see a disciplinary file under § 20-575 and § 20-579; the field visit already belongs to Drug Control. The same split applies in reverse: a candidate who emails Drug Control for a NAPLEX score-transfer question, or emails the Commission about a CPMRS connection failure, has chosen the wrong function even though both live at 450 Columbus Blvd.